Organization: MMV Financial Inc

TOPIGEN raises $26 million to accelerate clinical trials

Montreal-based TOPIGEN Pharmaceuticals Inc has secured $26 million in series C financing to accelerate Phase II clinical programs related to its lead products for respiratory therapeutics. The total raised to date from all sources is now $75 million and more may be added to the C series. Investors in the latest round are NovaQuest, MMV…

Nakina received US$10 million in financing

Nakina Systems Inc, Ottawa, has secured US$10 million in series B financing to accelerate product development and marketing and sales of its multi-vendor security systems for large telecom and data network vendors. The financing was led by VIMAC Ventures, Boston, with participation by EDC Equity, VenGrowth Capital Partners and MMV Financial Inc. VenGrowth provided the…